Laboratory monitoring of rivaroxaban and assessment of its bleeding risk.

CONCLUSIONS: Biophen DiXaI can be considered as a quantitative method to monitor the anticoagulation activity of rivaroxaban, and could be used to evaluate bleeding risk caused by rivaroxaban. The PT reagent (Thrombosis S) could be considered as a rough method to monitor the anticoagulation activity of rivaroxaban and evaluate bleeding risk caused by rivaroxaban. PMID: 27400196 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27400196?dopt=Abstract

Source: British Journal of Biomedical Science - July 13, 2016 Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research